miconazole + domiphen bromide
Development- Indications
- Vulvovaginal candidiasis
Company intelligence / Profile preview
Purna Pharmaceuticals is a Belgian CDMO specializing in the development and manufacturing of solid, semi-solid, and liquid pharmaceutical products. The company serves both large multinationals and small startups with end-to-end services from formulation to commercial production. It has a global presence with GMP/FDA-inspected facilities. Its own R&D projects include innovative formulations such as creams for vulvovaginal candidiasis currently in Phase 2 clinical trials. The company also exports medicines via tenders to NGOs and national authorities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Purna Pharmaceuticals.